LIPOXAL Trademark

Trademark Overview

On Friday, October 29, 2004, a trademark application was filed for LIPOXAL with the United States Patent and Trademark Office. The USPTO has given the LIPOXAL trademark a serial number of 79006722. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Thursday, October 30, 2014. This trademark is owned by REGULON A.E.. The LIPOXAL trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and formulations for use in the treatment of cancer
lipoxal

General Information

Serial Number79006722
Word MarkLIPOXAL
Filing DateFriday, October 29, 2004
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateThursday, October 30, 2014
Registration Number3093366
Registration DateTuesday, May 16, 2006
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, February 21, 2006

Trademark Statements

Goods and ServicesPharmaceutical preparations and formulations for use in the treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, September 6, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameREGULON A.E.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressGR-174 55 Alimos, Athina
GR
Party NameREGULON A.E.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressGR-174 55 Alimos, Athina
GR
Party NameREGULON A.E.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGR-174 55 Alimos, Athina
GR

Trademark Events

Event DateEvent Description
Friday, May 15, 2015NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Friday, May 15, 2015DEATH OF INTERNATIONAL REGISTRATION
Friday, November 14, 2014TOTAL INVALIDATION PROCESSED BY THE IB
Tuesday, August 19, 2014GENERIC MADRID TRANSACTION SENT TO IB
Tuesday, August 19, 2014GENERIC MADRID TRANSACTION CREATED
Tuesday, May 6, 2014TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, September 6, 2013CANCELLED SECTION 71
Friday, May 31, 2013NEW REPRESENTATIVE AT IB RECEIVED
Thursday, January 25, 2007FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, January 10, 2007FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, January 10, 2007FINAL DISPOSITION PROCESSED
Monday, November 20, 2006FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, May 16, 2006REGISTERED-PRINCIPAL REGISTER
Tuesday, February 21, 2006PUBLISHED FOR OPPOSITION
Wednesday, February 1, 2006NOTICE OF PUBLICATION
Monday, January 9, 2006LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, January 9, 2006AMENDMENT FROM APPLICANT ENTERED
Friday, January 6, 2006CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, January 6, 2006CORRECTION TRANSACTION RECEIVED FROM IB
Thursday, January 5, 2006ASSIGNED TO LIE
Wednesday, December 14, 2005APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 14, 2005AMENDMENT FROM APPLICANT ENTERED
Monday, November 21, 2005CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, November 21, 2005PAPER RECEIVED
Thursday, August 4, 2005IRREGULARITY FROM IB EXAMINED BY MPU
Thursday, July 14, 2005REFUSAL PROCESSED BY IB
Tuesday, June 28, 2005IRREGULARITY ON REFUSAL FROM IB
Thursday, June 23, 2005NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, June 4, 2005NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, June 3, 2005NON-FINAL ACTION WRITTEN
Friday, June 3, 2005ASSIGNED TO EXAMINER
Tuesday, December 21, 2004NEW APPLICATION ENTERED IN TRAM
Thursday, December 16, 2004SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

lipoxal cancer treatment formulations preparations pharmaceutical